According to Seres Therapeutics's latest financial reports the company's current earnings (TTM) are -โน12.25 B. In 2023 the company made an earning of -โน8.44 B an increase over its 2022 earnings that were of -โน20.49 B.The earnings displayed on this page is the company's Pretax Income.